Pregnancy outcomes in women with thalassemia in North America and the United Kingdom

Thompson, A. A.; Kim, H. Y.; Singer, S. T.; Vichinsky, E.; Eile, J.; Yamashita, R.; Giardina, P. J.; Olivieri, N.; Parmar, N.; Trachtenberg, F.; Neufeld, E. J.; Kwiatkowski, J. L.

Am J Hematol. 2013 Jun 13; 88(9):771-3


Improved survival in thalassemia has refocused attention on quality of life, including family planning. Understanding the issues associated with infertility and adverse pregnancy outcomes may impact clinical care of patients with thalassemia. We report the number and outcomes of pregnancies among subjects enrolled in Thalassemia Clinical Research Network (TCRN) registries and examine variables associated with successful childbirth. We identified 129 pregnancies in 72 women among the 264 women, age 18 years or older in our dataset. Over 70% of pregnancies resulted in live births and 73/83 (88%) of live births occurred at full term. Most pregnancies (78.2%) were conceived without reproductive technologies. Most (59.3%) pregnancies occurred while on chronic transfusion programs, however only 38.9% were on iron chelation. Four women developed heart problems. Iron burden in women who had conceived was not significantly different from age- and diagnosis-matched controls that had never been pregnant. There was also no difference in pregnancy outcomes associated with diagnosis, transfusion status, diabetes or Hepatitis C infection. Pregnancies occurred in 27.3% of women with thalassemia of child-bearing age in the TCRN registries, a notable increase from our previous 2004 report. With optimal health maintenance, successful pregnancies may be achievable. Am. J. Hematol. 88:771-773, 2013. (c) 2013 Wiley Periodicals, Inc.

Read More on PubMed